| Date | Time | Source | Headline | Symbol | Company |
| 04/18/2024 | 4:15PM | Business Wire | DermTech to Explore Strategic Alternatives and Implement Restructuring Plan | NASDAQ:DMTK | DermTech Inc |
| 04/01/2024 | 4:05PM | Business Wire | DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:DMTK | DermTech Inc |
| 03/08/2024 | 8:05AM | Business Wire | DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology | NASDAQ:DMTK | DermTech Inc |
| 03/07/2024 | 8:04PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:DMTK | DermTech Inc |
| 03/07/2024 | 8:01PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:DMTK | DermTech Inc |
| 03/07/2024 | 4:17PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:DMTK | DermTech Inc |
| 02/29/2024 | 4:53PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:DMTK | DermTech Inc |
| 02/29/2024 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:DMTK | DermTech Inc |
| 02/29/2024 | 4:01PM | Business Wire | DermTech Reports Fourth-Quarter 2023 Financial Results | NASDAQ:DMTK | DermTech Inc |
| 02/13/2024 | 8:05AM | Business Wire | DermTech Announces Release Date for Fourth-quarter 2023 Financial Results | NASDAQ:DMTK | DermTech Inc |
| 01/31/2024 | 4:32PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:DMTK | DermTech Inc |
| 01/31/2024 | 4:30PM | Business Wire | DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations | NASDAQ:DMTK | DermTech Inc |
| 01/18/2024 | 8:05AM | Business Wire | DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types | NASDAQ:DMTK | DermTech Inc |
| 01/16/2024 | 8:05AM | Business Wire | DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay | NASDAQ:DMTK | DermTech Inc |
| 01/09/2024 | 7:16PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:DMTK | DermTech Inc |
| 01/08/2024 | 8:00AM | Business Wire | DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT) | NASDAQ:DMTK | DermTech Inc |
| 12/14/2023 | 4:05PM | Business Wire | DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:DMTK | DermTech Inc |
| 12/11/2023 | 8:02PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:DMTK | DermTech Inc |
| 12/11/2023 | 8:02PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:DMTK | DermTech Inc |
| 12/11/2023 | 8:01PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:DMTK | DermTech Inc |
| 12/04/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK) | NASDAQ:DMTK | DermTech Inc |
| 11/28/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK) | NASDAQ:DMTK | DermTech Inc |
| 11/21/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK) | NASDAQ:DMTK | DermTech Inc |
| 11/14/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK) | NASDAQ:DMTK | DermTech Inc |
| 11/07/2023 | 1:57PM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK) | NASDAQ:DMTK | DermTech Inc |
| 11/02/2023 | 4:31PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:DMTK | DermTech Inc |
| 11/02/2023 | 4:09PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:DMTK | DermTech Inc |
| 11/02/2023 | 4:01PM | Business Wire | DermTech Reports Third-Quarter 2023 Financial Results | NASDAQ:DMTK | DermTech Inc |
| 10/31/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK) | NASDAQ:DMTK | DermTech Inc |
| 10/24/2023 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK) | NASDAQ:DMTK | DermTech Inc |